Therapeutic Asset Ratings

13,248 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Monepantel Motor Neuron Disease	Neurizon Therapeutics Limited	P1	CCC (50)
Niraparib Advanced Pancreatic Carcinoma	OHSU Knight Cancer Institute	P1	CCC (50)
NKG2D CAR-NK Refractory Metastatic Colorectal Cancer	Zhejiang University	P1	CCC (50)
nnc0442-0344 a Haemophilia A	Novo Nordisk A/S	P1	CCC (50)
Npt 2042 Epilepsy	NeuroPro Therapeutics, Inc.	P1	CCC (50)
Omacetaxine Hematologic Malignancies	University of Illinois at Chicago	P1	CCC (50)
Pralatrexate Cutaneous T-cell Lymphoma	University of Virginia	P1	CCC (50)
SAFIMALTIB Lymphoma, Non-Hodgkin	Janssen Research & Development, LLC	P1	CCC (50)
Semaglutide Primary Biliary Cholangitis	Cascade Pharmaceuticals, Inc	P1	CCC (50)
sl-172154 Platinum-Resistant Primary Peritoneal Carcinoma	Shattuck Labs, Inc.	P1	CCC (50)
Sorafenib Recurrent Adult Acute Myeloid Leukemia	National Cancer Institute (NCI)	P1	CCC (50)
Tenofovir Amibufenamide Chronic Hepatitis B Liver Fibrosis	Ningbo No.2 Hospital	P1	CCC (50)
TIL Advanced Liver Cancers	Shanghai Juncell Therapeutics	P1	CCC (50)
TIL Advanced Pancreatic Cancers	City of Hope Medical Center	P1	CCC (50)
Ucar T-Cell ANCA Associated Systemic Vasculitis	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (50)
Ucar T-Cell IgA Nephropathy (IgAN)	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (50)
Ucar T-Cell Systemic Lupus Erthematosus (SLE)	The Children's Hospital of Zhejiang University School of Medicine	P1	CCC (50)
XENON COPD	University of Kansas Medical Center	P1	CCC (50)
Capecitabine Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P1	CCC (49)
Cetuximab Dynamic Tumor Resistance	National Cancer Institute (NCI)	P1	CCC (49)
Humulin R Insulin Resistance	University of Missouri-Columbia	P1	CCC (49)
Irinotecan Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P1	CCC (49)
Letrozole Sickle Cell Disease	Pfizer	P1	CCC (49)
Pembrolizumab Myelodysplastic Syndromes	City of Hope Medical Center	P1	CCC (49)
PROPRANOLOL Fallopian Tube Cancer	Memorial Sloan Kettering Cancer Center	P1	CCC (49)

Showing 151 to 175 of 13,248 assets

PreviousPage 7 of 530Next